Industry Notes / Pharma / Chapter 12 of 20 · Bar

What kind of company China can grow

Ammunition plants and engineering platforms grow; Lilly-style brand giants rarely do

China’s endowment is cost × speed × manufacturing, not foundation-style patient capital. Market-cap ceilings track how much US net-price profit—or global outsourcing orders—you can capture. The chart puts Lilly near $1.12 tn against a rough China top-tier sketch of about $50 bn.

Source：礼来市值：YCharts/TradingEconomics（2026-08）；中国医药市值第一梯队量级为公开市值区间示意

Research notes, not investment advice.